Bintrafusp Alfa and PDS01ADC Trial
Phase 1
100
about 7.4 years
18–120
1 site in MD
What this study is about
Researchers are testing a treatment with M7824, PDS01ADC, and SBRT to see if it can help fight cancer that has spread. Participants will receive these treatments through injections and infusions over several months while also providing samples for research purposes. The trial will last approximately 2 years.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Stereotactic body radiation therapy (SBRT)
- 2.Take M7824
- 3.Take PDS01ADC
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: safety and tolerability of PDS01ADC and M7824 alone or in combination with SBRT
Secondary: Objective response rate (ORR), Overall Survival (OS), Progression free survival (PFS)
Oncology